Talaei Ali, Afzaljavan Fahimeh, Niroumand Shabnam, Nejati Raheleh
Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Addict Health. 2021 Jul;13(3):176-184. doi: 10.22122/ahj.v13i3.311.
Respiratory disorders during sleep are considered a health problem affecting the life quality. There is some evidence indicating the higher prevalence of apnea in substance-dependent patients. However, there is no information on the prevalence of the disease in people under methadone maintenance therapy (MMT). Therefore, the present study was designed to estimate the disease rate in these patients and consider the relationship of the increasing risk of apnea with some psychiatric problems.
Study group included 152 individuals under the MMT program. Baseline data were collected with the interview, and patients were considered using the STOP-BANG questionnaire to evaluate the risk of apnea. Furthermore, Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Hamilton Anxiety Rating Scale (HAM-A), and Hamilton Depression Rating Scale (HDRS) tests were performed for all participants. Data were analyzed using SPSS software.
Based on the STOP-BANG score categories, 37.5%, 40.1%, and 22.4% of patients indicated low, intermediate, and high risk of apnea, respectively. Moreover, severe daytime sleepiness, fatigue, depression, and anxiety were observed in 5.3%, 5.5%, 6.0%, and 21.1% of participants, respectively. Sex (P = 0.007) and daytime sleepiness (P = 0.048) were significantly different between low and high-risk groups of apnea after adjustment. Besides, age (P < 0.001) and fatigue (P = 0.007) were factors predicting the STOP-BANG score.
These findings revealed the higher prevalence of apnea in MMT patients compared to the general population of Iran and rising of the risk of apnea along with an increase in age and fatigue score. However, attention to the sleep disorders in MMT is a prominent factor that should be considered as a route of therapy.
睡眠期间的呼吸障碍被认为是一个影响生活质量的健康问题。有证据表明物质依赖患者中呼吸暂停的患病率较高。然而,关于接受美沙酮维持治疗(MMT)的人群中该疾病的患病率尚无相关信息。因此,本研究旨在评估这些患者的疾病发生率,并探讨呼吸暂停风险增加与一些精神问题之间的关系。
研究组包括152名接受MMT项目的个体。通过访谈收集基线数据,并使用STOP-BANG问卷评估患者的呼吸暂停风险。此外,对所有参与者进行了爱泼华嗜睡量表(ESS)、疲劳严重程度量表(FSS)、汉密尔顿焦虑评定量表(HAM-A)和汉密尔顿抑郁评定量表(HDRS)测试。使用SPSS软件对数据进行分析。
根据STOP-BANG评分类别,分别有37.5%、40.1%和22.4%的患者显示出低、中和高呼吸暂停风险。此外,分别有5.3%、5.5%、6.0%和21.1%的参与者存在严重的日间嗜睡、疲劳、抑郁和焦虑。调整后,呼吸暂停低风险组和高风险组之间的性别(P = 0.007)和日间嗜睡(P = 0.048)存在显著差异。此外,年龄(P < 0.001)和疲劳(P = 0.007)是预测STOP-BANG评分的因素。
这些发现表明,与伊朗普通人群相比,MMT患者中呼吸暂停的患病率更高,且呼吸暂停风险随着年龄和疲劳评分的增加而上升。然而,关注MMT中的睡眠障碍是一个突出因素,应被视为一种治疗途径。